DDX24 and myeloid sarcoma: We therefore can speculate a mechanism by which autoantibodies against TCERG1 and DDX24 might exert a pathogenetic role in MS inducing or sustaining neurodegeneration by impairing the functions of their target proteins either inducing misplacement or blocking their activity.